Cargando…
Nigella Sativa Supplementation Accelerates Recovery from Mild COVID-19: First Randomized Controlled Trial
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier GmbH
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8696021/ http://dx.doi.org/10.1016/j.eujim.2021.101899 |
_version_ | 1784619712496271360 |
---|---|
author | Koshak, Abdulrahman Koshak, Emad A Mobeireek, Abdullah F Badawi, Mazen A Wali, Siraj O Malibary, Husam M Atwah, Ali F Alhamdan, Meshari M Almalki, Reem A Madani, Tariq A |
author_facet | Koshak, Abdulrahman Koshak, Emad A Mobeireek, Abdullah F Badawi, Mazen A Wali, Siraj O Malibary, Husam M Atwah, Ali F Alhamdan, Meshari M Almalki, Reem A Madani, Tariq A |
author_sort | Koshak, Abdulrahman |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8696021 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Published by Elsevier GmbH |
record_format | MEDLINE/PubMed |
spelling | pubmed-86960212021-12-23 Nigella Sativa Supplementation Accelerates Recovery from Mild COVID-19: First Randomized Controlled Trial Koshak, Abdulrahman Koshak, Emad A Mobeireek, Abdullah F Badawi, Mazen A Wali, Siraj O Malibary, Husam M Atwah, Ali F Alhamdan, Meshari M Almalki, Reem A Madani, Tariq A Eur J Integr Med Article Published by Elsevier GmbH 2021-12 2021-12-17 /pmc/articles/PMC8696021/ http://dx.doi.org/10.1016/j.eujim.2021.101899 Text en Copyright © 2021 Published by Elsevier GmbH. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Koshak, Abdulrahman Koshak, Emad A Mobeireek, Abdullah F Badawi, Mazen A Wali, Siraj O Malibary, Husam M Atwah, Ali F Alhamdan, Meshari M Almalki, Reem A Madani, Tariq A Nigella Sativa Supplementation Accelerates Recovery from Mild COVID-19: First Randomized Controlled Trial |
title | Nigella Sativa Supplementation Accelerates Recovery from Mild COVID-19: First Randomized Controlled Trial |
title_full | Nigella Sativa Supplementation Accelerates Recovery from Mild COVID-19: First Randomized Controlled Trial |
title_fullStr | Nigella Sativa Supplementation Accelerates Recovery from Mild COVID-19: First Randomized Controlled Trial |
title_full_unstemmed | Nigella Sativa Supplementation Accelerates Recovery from Mild COVID-19: First Randomized Controlled Trial |
title_short | Nigella Sativa Supplementation Accelerates Recovery from Mild COVID-19: First Randomized Controlled Trial |
title_sort | nigella sativa supplementation accelerates recovery from mild covid-19: first randomized controlled trial |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8696021/ http://dx.doi.org/10.1016/j.eujim.2021.101899 |
work_keys_str_mv | AT koshakabdulrahman nigellasativasupplementationacceleratesrecoveryfrommildcovid19firstrandomizedcontrolledtrial AT koshakemada nigellasativasupplementationacceleratesrecoveryfrommildcovid19firstrandomizedcontrolledtrial AT mobeireekabdullahf nigellasativasupplementationacceleratesrecoveryfrommildcovid19firstrandomizedcontrolledtrial AT badawimazena nigellasativasupplementationacceleratesrecoveryfrommildcovid19firstrandomizedcontrolledtrial AT walisirajo nigellasativasupplementationacceleratesrecoveryfrommildcovid19firstrandomizedcontrolledtrial AT malibaryhusamm nigellasativasupplementationacceleratesrecoveryfrommildcovid19firstrandomizedcontrolledtrial AT atwahalif nigellasativasupplementationacceleratesrecoveryfrommildcovid19firstrandomizedcontrolledtrial AT alhamdanmesharim nigellasativasupplementationacceleratesrecoveryfrommildcovid19firstrandomizedcontrolledtrial AT almalkireema nigellasativasupplementationacceleratesrecoveryfrommildcovid19firstrandomizedcontrolledtrial AT madanitariqa nigellasativasupplementationacceleratesrecoveryfrommildcovid19firstrandomizedcontrolledtrial |